Physician profile
Jane L Rupp
NPI 1881469237
$3,623.13
in general payments reported to CMS, 2019-2025
11 companies · $2,218 in 2025
The $2,218 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,405 · 2025: $2,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,623.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,038.20 | 2024-2025 | |
| Madrigal Pharmaceuticals | $845.78 | 2024-2025 | Rezdiffra, Resmetirom |
| Ardelyx, INC. | $562.38 | 2024-2025 | Ibsrela |
| Gilead Sciences, INC. | $462.11 | 2024-2025 | Livdelzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $241.37 | 2024-2025 | Xifaxan |
| Vivus LLC | $155.02 | 2024-2025 | Pancreaze |
| Phathom Pharmaceuticals, INC. | $104.35 | 2024 | Voquezna |
| Ipsen Biopharmaceuticals, INC | $80.40 | 2024-2025 | Iqirvo |
| Merck Sharp & Dohme LLC | $67.19 | 2024 | Dificid |
| Aimmune Therapeutics, INC. | $37.24 | 2024 | |
| Exact Sciences Corporation | $29.09 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Rupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.